UnitedHealth Group (UNH) Q4 and Annual 2025 Earnings
UnitedHealth Group reported Q4 2025 revenue of $113.22B (+12.3% YoY), missed analyst consensus of $113.77B by $556.8M. Diluted EPS came in at $2.11 (-69.0% YoY), beat the $2.10 consensus by $0.01. UnitedHealth Group reports across 4 business segments, led by UnitedHealthcare, Optum Health, and Optum Rx.
Financial Snapshot
Trailing eight quarters through Q4 2025
Q4 2025 Earnings FAQ
Common questions about UnitedHealth Group's Q4 2025 earnings report.
UnitedHealth Group (UNH) reported Q4 2025 earnings on January 27, 2026 before market open.
UnitedHealth Group reported revenue of $113.22B and diluted EPS of $2.11 for Q4 2025.
Revenue missed the consensus estimate of $113.77B by $556.8M. EPS beat the consensus estimate of $2.10 by $0.01.
Compared to the same quarter a year prior, revenue grew 12.3% from $100.81B a year earlier and diluted EPS declined 69.0% from $6.81.
UnitedHealth Group reports across 4 business segments, led by UnitedHealthcare, Optum Health, and Optum Rx. Segment-level financials are available on the company's metrics pages.
You can read the 8-K earnings release (0000731766-26-000025) and the 10-K periodic report (0000731766-26-000062) directly on SEC EDGAR. The filing index links above go to sec.gov.